Tuesday, November 29, 2011

The Combination of Aricept and Namenda Helps Slow the Rate of Decline in Alzheimer's Patients

"The results of this study should change the way we treat patients with Alzheimer's disease. Cholinesterase inhibitors are approved for use in mild to moderate dementia, while memantine has been approved for advanced dementia. But it looks like there is an advantage in prescribing both drugs (Aricept and Namenda) as initial treatment."--John Growdon, MD
Read more at www.alzheimersreadingroom.com